As of October 11, 54 senators joined Sens. Durbin and Blunt to oppose the Senate version of the National Defense Authorization Act (NDAA) that contains language that would severely restrict critical medical research programs.
The research funded includes colorectal cancer and several other cancer-specific research efforts through the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP). The current language would severely restrict the criteria for eligible research, in some cases terminating potentially life-saving medical research.
The House passed the NDAA bill, but the House version DOES NOT include this harmful, restrictive language. As the House and Senate convene a conference committee to reconcile the two versions of the NDAA, we are calling on YOU to voice your opposition to the harmful language contained in the Senate version of the bill!
Take action by urging your representative in the House to sign on to a letter requesting their colleagues remove this language and protect the CDMRP!